UK Antimicrobial Registry

Collecting real world antimicrobial data, improving patient outcomes

19th June 2020

Call for University Partner to run UKAR

Expressions of interest are now open with a deadline of July 10th.

Call for partner university and principal investigator for the further development of a UK Antimicrobial Registry (UKAR).

 The British Society for Antimicrobial Chemotherapy  is establishing a UK Drug Registry (UKAR) to provide prescribers and organisations the opportunity to capture real world usage of antimicrobial agents and identify where the real clinical unmet need lies. This will provide an invaluable resource for future research studies and also enable the sharing of best practice.

The Registry will be a collaborative epidemiological study through which BSAC partnerships with a UK university and industry partners.  It  will be a central activity through which BSAC and partners will support the antimicrobial community in increasing positive outcomes for patients while helping to contain and control the threat of antimicrobial resistance. The Registry will initially be open for intravenous antibiotics, with a particular focus on multi-drug resistant organisms.

The registry will be overseen by an expert steering group to ensure appropriate consent and governance at all levels of implementation.

BSAC is now looking to engage a lead principal investigator to lead the study and also engage with a university partner who has experience of running other patient registries.

 This will be a lean and efficient project with tight timescales but is an exciting opportunity to be part of a programme with national and international importance.

 Please complete the contact form to express interest as a university partner, investigator or industry organisation or contact Tracey Guise, CEO of BSAC directly by email